JonesResearch Starts Coverage on Atai Beckley & Mind Medicine with Buy Ratings
JonesResearch gives Buy ratings to Atai Beckley and Mind Medicine, highlighting potential in psychedelic drug development for depression and anxiety.
NOTRELOAD AI
Oppenheimer Starts Coverage on Aardvark Therapeutics with Strong Rating
Oppenheimer analyst gives Aardvark Therapeutics an Outperform rating with $35 price target, highlighting rare and common obesity drug programs and a key Phase 3 trial.
Oppenheimer Starts Coverage on Spruce Biosciences with Bullish Outlook
Oppenheimer initiates coverage of Spruce Biosciences with an Outperform rating, citing strong FDA signals, accelerated approval potential, and possible acquisition interest from BioMarin.
Coinbase Buys The Clearing Company to Expand Prediction Markets
Coinbase acquires The Clearing Company to strengthen its prediction markets platform, bringing in expert team from Kalshi and Polymarket as part of its "Everything Exchange" strategy.
Trump Unveils New "Trump-Class" Battleships for His "Golden Fleet"
President Trump announces plans to build up to 25 new Trump-class battleships starting with USS Defiant, aiming to revitalize U.S. naval power and shipbuilding amid competition with China.
Cantor Fitzgerald Starts Coverage on ArriVent Biopharma with Strong Upside
Cantor Fitzgerald initiates coverage on ArriVent Biopharma with an Overweight rating, highlighting strong Phase 3 potential and significant upside.